GlaxoSmithKline Blog | Talkmarkets | Page 1
No data available
No data available

People who follow this stock (347)

Latest Posts

About This Stock More About This Stock
18 Drugs To Lose Patents In 2017; Could Jeopardize $26.5B For Big Pharma
Article By: Lorimer Wilson
Saturday, April 22, 2017 8:24 PM EDT
With 18 branded drugs on the line, patent losses this year could jeopardize $26.5 billion in annual sales from Big Pharma, projected to be the biggest fall-off until at least 2025.
In this article: AZN, BMY, GSK, LLY, MRK, PFE, SNY, RHHBY, TEVA
Read
Glaxosmithkline: A High Yield But A Lot Of Risks To Consider
Article By: Simply Safe Dividends
Thursday, April 6, 2017 1:40 AM EDT
As the market continues to climb to new record highs, many investors are searching for safe dividend stocks paying high dividends. Let’s take a look at to see if GlaxoSmithKline could be a reasonable investment.
In this article: GSK Also: BMY, JNJ, MRK, GILD
Read
E Breaking Down VBI Vaccines' Pipeline: Descriptions And Catalysts
Article By: Samuel Rae
Saturday, February 18, 2017 1:12 PM EDT
Here's a look at VBI Vaccines' (VBIV) pipeline and the events that should drive value for the company going forward; with caveats.
In this article: GSK, SNY, VBIV Also: OPK
Read
Week In Review: China To Add 300 Drugs To National Reimbursement Drug List
Article By: ChinaBio® Today
Saturday, February 4, 2017 1:21 PM EDT
According to sources, China is getting close to announcing a revised National Reimbursement Drug List, the group of drugs covered by China's national insurance plan. 130 will be chemical drugs and the rest will be traditional Chinese medicines.
In this article: AZN, GSK, FGEN
Read
Trump + Stocks: The Week In Review
Article By: The Fly
Friday, January 13, 2017 7:44 PM EDT
Weekly recap of stocks that are being impacted, or are predicted to be impacted, by the comments, actions and policies of President-elect Trump and his administration.
In this article: GSK, JNJ, JPM, LLY, LMT Also: AXP, NVS, PFE, PNR, ROP, SNY, EHTH, TRS, ENDP, MYL, MNK
Read

PARTNER HEADLINES

Latest Tweets for $GSK

No tweets yet!